|
TRAPPC2 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.32116539930394E-14 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.02059999954152E-07 |
| Normal-vs-Stage2 |
3.11870000002656E-06 |
| Normal-vs-Stage3 |
N/A |
| Normal-vs-Stage4 |
4.555600E-03 |
| Stage1-vs-Stage2 |
4.879600E-01 |
| Stage1-vs-Stage3 |
N/A |
| Stage1-vs-Stage4 |
5.982800E-01 |
| Stage2-vs-Stage3 |
N/A |
| Stage2-vs-Stage4 |
9.920800E-01 |
| Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.32391883514538E-12 |
| Normal-vs-AfricanAmerican |
1.166970E-01 |
| Normal-vs-Asian |
3.360400E-02 |
| Caucasian-vs-AfricanAmerican |
2.509800E-01 |
| Caucasian-vs-Asian |
4.710600E-01 |
| AfricanAmerican-vs-Asian |
9.671600E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.47079999996058E-06 |
| Normal-vs-Female |
5.91619975232049E-10 |
| Male-vs-Female |
1.053410E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.795080E-04 |
| Normal-vs-Extreme_Weight |
1.01929999996031E-08 |
| Normal-vs-Obese |
2.300100E-03 |
| Normal-vs-Extreme_Obese |
N/A |
| Normal_Weight-vs-Extreme_Weight |
1.181740E-02 |
| Normal_Weight-vs-Obese |
1.234960E-01 |
| Normal_Weight-vs-Extreme_Obese |
N/A |
| Extreme_Weight-vs-Obese |
9.770800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
N/A |
| Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
N/A |
| Normal-vs-Grade 2 |
7.524400E-01 |
| Normal-vs-Grade 3 |
5.829600E-01 |
| Normal-vs-Grade 4 |
1.000000E+00 |
| Grade 1-vs-Grade 2 |
N/A |
| Grade 1-vs-Grade 3 |
N/A |
| Grade 1-vs-Grade 4 |
N/A |
| Grade 2-vs-Grade 3 |
6.584800E-01 |
| Grade 2-vs-Grade 4 |
7.524400E-01 |
| Grade 3-vs-Grade 4 |
5.829600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.63690189075783E-11 |
| Normal-vs-N1 |
1.100280E-02 |
| N0-vs-N1 |
2.571800E-01 |
|
|
